Health

The field of cancer research and treatment is constantly evolving, with new advancements and studies being conducted regularly. In this article, we will critically analyze recent developments and findings in the world of oncology. One interesting study conducted by Penn Medicine and published in the American Journal of Preventive Medicine highlighted the importance of patient
0 Comments
Ozanimod, a sphingosine-1-phosphate (S1P) receptor modulator, has long been associated with warnings against its usage during pregnancy due to potential complications. However, a recent study presented at the Advances in Inflammatory Bowel Diseases annual meeting challenges this notion. The study examined the pregnancy outcomes of women with inflammatory bowel disease (IBD) and relapsing multiple sclerosis
0 Comments
Women who have previously undergone a cesarean section face a challenging decision when considering their mode of delivery for subsequent pregnancies. While planning another cesarean delivery may carry a higher risk of maternal complications, attempting vaginal delivery is associated with increased risks of uterine rupture and perinatal complications. To address this dilemma, the Canadian PRISMA
0 Comments
The recent FDA approval of zuranolone, a pill specifically designed to treat postpartum depression (PPD), is undoubtedly a significant scientific achievement. With two successful phase III trials, zuranolone joins the IV infused brexanolone as the only approved psychopharmacological treatments for PPD. The development of these drugs, which target allopregnanolone and modulate the GABAA receptor, not
0 Comments
The healthcare industry is embarking on a transformative journey towards nationwide interoperability, as five pioneering healthcare companies take a momentous step towards creating a network for exchanging patient health information. HHS Secretary Xavier Becerra described this achievement as witnessing the “Big Bang” of healthcare information exchange in 2023. By joining forces in a private-public partnership,
0 Comments